Nov 23, 2009, 1:42 PM EDT
As usual the Marlins are going to spend the offseason cutting payroll and trading players making more than minimum salaries, but MLB.com’s Joe Frisaro reports that they’re “almost 100 percent” certain to keep Jorge Cantu.
On the heels of apparently balking at 25-year-old ace Josh Johnson’s long-term contract demands, the decision to hang onto Cantu of all players is very odd. Cantu is a good but not great hitter, a horrible defensive third baseman who should be at first base, and will likely make more than $5 million in 2010 via arbitration.
If anything he’s one of the guys Florida should specifically be looking to trade, because he’s expensive without being close to an elite player and has only one season left before free agency. Cantu tallied 100 RBIs this year, but his .289/.345/.443 line and 16 homers in 643 plate appearances were hardly special for a first baseman (or terrible defensive third baseman) and he’s a career .278/.323/.456 hitter. For comparison, the average MLB first baseman hit .277/.363/.483 this year.
Cantu would be a decent pickup for a contending team that has money to burn and just needs one more solid bat to plug into a strong lineup, but for a low-payroll team that is constantly forced to juggle players he makes little sense. They could get 90 percent of the production at 10 percent of the cost, add a couple prospects, and use the money saved to actually retain some truly elite players.
- MLB hands down the suspensions for Tuesday night’s Dodgers-Diamondbacks melee (111)
- Democrats beat the Republicans 22-0 in the Congressional Baseball Game (98)
- And That Happened: Wednesday’s scores and highlights (97)
- And That Happened: Thursday’s scores and highlights (88)
- And That Happened: Monday’s scores and highlights (84)
- Blackhawks win OT thriller
- PFT: Report: Hernandez accused of prior shooting
- CSN: Report: Hernandez 'not ruled out' as suspect
- PBT: Celts, Clips restart Doc, KG trade talks
- Posnanski: How Heat won a game of mistakes
- GTC: Tiger pulls out of AT&T citing elbow issue
- HBT: Biogenesis suspensions still likely coming